Fig 3. Probability that the change in CD4 threshold is cost-effective, by time horizon and willingness to pay per DALY averted.

Black lines indicate where 25%, 50%, 75%, and 100% of parameter sets are cost-effective. Horizontal dashed lines indicate one and three times Uganda’s per capita GDP.